Episode 271: Advancing Neurotrauma Treatments with Ken Webb of NeuroHope Therapeutics
About this episode
Ken Webb discusses advancements in neurotrauma treatments and his journey as an academic entrepreneur.
Recorded at the 2026 SCbio Annual Conference in Charleston, Heather and Matthew welcome Ken Webb, Professor of Bioengineering at Clemson University and Co‑Founder and President of NeuroHope Therapeutics. We have an exciting conversation about how Ken’s research team is developing and commercializing novel drug‑delivery technologies aimed at treating central nervous system trauma, including spinal cord and traumatic brain injuries. Ken also reflects on his journey as an academic entrepreneur, the role of SCbio and other partners in supporting early‑stage life sciences startups, and what he sees ahead for innovation at the intersection of science and patient care. Tune in for insights on cutting‑edge research with a life-changing impact.
More episodes of Taking the Pulse: a Health Care and Life Sciences Podcast
- Episode 278: Equipping Health Systems with the Right AI Solutions with Dr. Mark Sendak of Vega Health
- Episode 277: M&A Trends and Growth in the Life Sciences Industry with John Erwin of Maynard Nexsen
- Episode 276: Educating the Life Sciences Workforce with Wake Tech’s Leslie Isenhour
- Episode 274: Advancing Cancer Immunotherapy with Dr. Besim Ogretmen of Lipo‑Immuno Tech & MUSC
- Episode 273: Navigating FDA Regulation for Life Sciences Companies with Christin Carey of Maynard Nexsen
- Episode 272: Humanism and Transplant Care with Dr. Joseph Scalea of MUSC
Explore listener stats, chart rankings, contacts and more on the Taking the Pulse: a Health Care and Life Sciences Podcast podcast page.